Drugmaker, Novartis, has issued a voluntary recall of 1,645 lots of Excedrin, NoDoz, Bufferin and Gas-X Prevention, over concerns that some of the bottles may contain stray prescription pain killers, as well as broken or chipped pills.
The Novartis recall affects all Bufferin and Gas-X Prevention products with expiration dates of December 20, 2013 or earlier. The recall also affects the following Excedrin products with expiration dates of December 20, 2014:
Excedrin Extra Strength Caplets
Excedrin Extra Strength Express Gel Caplets
Excedrin Extra Strength Gel Caplets
Excedrin Extra Strength Tablets
Excedrin Back & Body Caplets
Excedrin Sinus Headache Caplets
Excedrin Migraine Caplets
Excedrin Migraine Gel Tablets
Excedrin Migraine Tablets
Excedrin Menstrual Complete Express Gel Caplets
Excedrin PM Caplets
Excedrin PM Express Gel Caplets
Excedrin PM Tablets
Excedrin Tension Headache Caplets
Excedrin Tension Headache Express Gel Caplets
Excedrin Tension Headache Gel Tablets
To date, federal regulators have not received any reports of adverse events stemming from the precautionary recall. Mixing different pills in the same bottle can be extremely dangerous, as consumers could inadvertently take the wrong product, which could cause consumers to suffer an overdose or an allergic reaction from injecting an unintended ingredient.
